What is the address of MEDILOC SA?

The registered office of MEDILOC SA is located at Sclassin 1, 4861 Pepinster.

Is MEDILOC SA still active?

Yes. According to the CBE (30 October 2026) MEDILOC SA is active, legal situation “Normale toestand”, started on 23 August 2002.

Is MEDILOC SA registered on Peppol?

No, MEDILOC SA is currently not registered on the Peppol network.

What is the enterprise number of MEDILOC SA?

The enterprise number of MEDILOC SA is BE0478201981.

When was MEDILOC SA founded?

MEDILOC SA was founded on 23 August 2002.

Who are the directors of MEDILOC SA?

According to the 2025 annual accounts, the directors of MEDILOC SA are: Jean-Michel CRIELAARD, Juliette DAIROMONT.

Is MEDILOC SA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 23 August 2002; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did MEDILOC SA make in 2025?

MEDILOC SA posted a profit after taxes of € 14,309 in financial year 2025.

What is the revenue of MEDILOC SA?

As a small company, MEDILOC SA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 68,550.

MEDILOC SA (Public Limited) - Pepinster - BE0478201981

Dossier MEDILOC SA, printed on 30 October 2026 from databakkes.be/en/0478201981/mediloc-sa. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

MEDILOC SA from Pepinster, company number BE0478201981, closed financial year 2025 with a result of € 14,309 after tax. For that financial year MEDILOC SA recorded a gross margin of € 68,550 and equity of € 495,753. Compared with financial year 2024, the result moved from € -11,913 to € 14,309. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.

What it is worth Growing

€ 495,753

▲ 3% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 14,309

▲ still € 11,913 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 95,522

▲ 113% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 365,456.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Taxes

€ 3,471

▼ 40% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 62,759 Gross margin 2022: € 62,759 First fiscal year in the series	€ 63,567 Gross margin 2023: € 63,567 ▲ 1% vs 2022 (€ 62,759) Favourable step	€ 71,270 Gross margin 2024: € 71,270 ▲ 12% vs 2023 (€ 63,567) Favourable step	€ 68,550 Gross margin 2025: € 68,550 ▼ 4% vs 2024 (€ 71,270) Unfavourable step	▼ 4%
Profit after taxes	€ -6,488 Profit after taxes 2022: € -6,488 First fiscal year in the series	€ -10,458 Profit after taxes 2023: € -10,458 ▼ € 3,970 vs 2022 (€ -6,488) Unfavourable step	€ -11,913 Profit after taxes 2024: € -11,913 ▼ € 1,455 vs 2023 (€ -10,458) Unfavourable step	€ 14,309 Profit after taxes 2025: € 14,309 ▲ € 26,222 vs 2024 (€ -11,913) Favourable step	▲ € 26,222
Equity	€ 503,815 Equity 2022: € 503,815 First fiscal year in the series	€ 493,357 Equity 2023: € 493,357 ▼ 2% vs 2022 (€ 503,815) Unfavourable step	€ 481,444 Equity 2024: € 481,444 ▼ 2% vs 2023 (€ 493,357) Unfavourable step	€ 495,753 Equity 2025: € 495,753 ▲ 3% vs 2024 (€ 481,444) Favourable step	▲ 3%
Total debts	€ 162,086 Total debts 2022: € 162,086 First fiscal year in the series	€ 160,405 Total debts 2023: € 160,405 ▼ 1% vs 2022 (€ 162,086) Favourable step	€ 167,267 Total debts 2024: € 167,267 ▲ 4% vs 2023 (€ 160,405) Unfavourable step	€ 163,411 Total debts 2025: € 163,411 ▼ 2% vs 2024 (€ 167,267) Favourable step	▼ 2%
Cash	€ 141,817 Cash 2022: € 141,817 First fiscal year in the series	€ 95,776 Cash 2023: € 95,776 ▼ 32% vs 2022 (€ 141,817) Unfavourable step	€ 44,888 Cash 2024: € 44,888 ▼ 53% vs 2023 (€ 95,776) Unfavourable step	€ 95,522 Cash 2025: € 95,522 ▲ 113% vs 2024 (€ 44,888) Favourable step	▲ 113%
Land & buildings	€ 260,694 Land & buildings 2022: € 260,694 First fiscal year in the series	€ 297,316 Land & buildings 2023: € 297,316 ▲ 14% vs 2022 (€ 260,694) Unchanged	€ 347,848 Land & buildings 2024: € 347,848 ▲ 17% vs 2023 (€ 297,316) Unchanged	€ 305,262 Land & buildings 2025: € 305,262 ▼ 12% vs 2024 (€ 347,848) Unchanged	▼ 12%
Retained profit	€ 373,518 Retained profit 2022: € 373,518 First fiscal year in the series	€ 363,060 Retained profit 2023: € 363,060 ▼ 3% vs 2022 (€ 373,518) Unfavourable step	€ 351,147 Retained profit 2024: € 351,147 ▼ 3% vs 2023 (€ 363,060) Unfavourable step	€ 365,456 Retained profit 2025: € 365,456 ▲ 4% vs 2024 (€ 351,147) Favourable step	▲ 4%
Balance sheet total	€ 665,901 Balance sheet total 2022: € 665,901 First fiscal year in the series	€ 653,762 Balance sheet total 2023: € 653,762 ▼ 2% vs 2022 (€ 665,901) Unchanged	€ 648,711 Balance sheet total 2024: € 648,711 ▼ 1% vs 2023 (€ 653,762) Unchanged	€ 659,164 Balance sheet total 2025: € 659,164 ▲ 2% vs 2024 (€ 648,711) Unchanged	▲ 2%

Key figures of MEDILOC SA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEDILOC SA?

What happened at MEDILOC SA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 31, 2026 New annual accounts for financial year 2025: profit of € 14,309. Source: NBB ↗
Aug 23, 2002 Start of the company according to the CBE. KBO
Aug 12, 2002 New establishment in Pepinster. KBO

In short

From € 6,488 loss in 2022 to € 14,309 profit in 2025.

Paid € 1,431 in corporate taxes since 2022.

Best year ever: 2025, with € 14,309 profit.

Original PDFs at the National Bank ↗

Management

Jean-Michel CRIELAARD Juliette DAIROMONT

CRIELAARD KOLLEGIUM - Défense Expertises Médicales

MEDILOC SA

Behind MEDILOC SA are Jean-Michel CRIELAARD and Juliette DAIROMONT. Jean-Michel CRIELAARD is also behind CRIELAARD KOLLEGIUM - Défense Expertises Médicales.

Directors

According to the 2025 annual accounts

Jean-Michel CRIELAARD

Managing director

Also active at: CRIELAARD KOLLEGIUM - Défense Expertises Médicales

Juliette DAIROMONT

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Sclassin 1

4861 Pepinster

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

NOUGAMA & PARTNERS

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0478.201.981
VAT number: BE 0478.201.981
Registered office: Sclassin 1, 4861 Pepinster
Names & denominations: MEDILOC SA
Enterprise type: Rechtspersoon
Legal form: Public limited company
Legal situation: Normale toestand
Start date: 23 August 2002
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗